WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 16 fonti

After Makary departure, CDER chief Tracy Beth Høeg likely headed out at FDA: report

With the ink barely dry on outgoing commissioner Marty Makary’s resignation, another top regulator may be heading for the exit at the FDA.  | With the ink barely dry on outgoing commissioner Marty Makary’s resignation, another top regulator may be heading for the exit at the FDA.

Raccontata daaxios.comhuffpost.compolitico.comusatoday.comrollcall.combiopharmadive.comendpoints.newsthedispatch.comfiercepharma.comnbcnews.comcnbc.comcbsnews.com+4 altre

Confronto fonti

6 prospettive sulla stessa storia
AI · summaries
fiercepharma.comStai leggendo1 mesi fa

After Makary departure, CDER chief Tracy Beth Høeg likely headed out at FDA: report

With the ink barely dry on outgoing commissioner Marty Makary’s resignation, another top regulator may be heading for the exit at the FDA.  | With the ink barely dry on outgoing commissioner Marty Makary’s resignation,…

originale

Timeline cronologica

  1. martedì 12 maggio 2026·axios.com

    Marty Makary out as FDA chief

    His tenure was marked by organizational upheaval, controversies over drug approvals and tensions with the White House.

  2. martedì 12 maggio 2026·huffpost.com

    Trump FDA Chief Is Leaving After Angering Pharma CEOs, Vaping Lobbyists And Anti-Abortion Groups

    Marty Makary is resigning after just over a year leading the powerful health regulatory agency.

nbcnews.com
1 mesi fa

FDA leadership shake-up continues with departure of top drug regulator

Dr. Tracy Beth Høeg is leaving her role as head of the FDA’s Center for Drug Evaluation and Research, just days after FDA chief Marty Makary resigned.

Leggi questa versione → originale
economictimes.indiatimes.com1 mesi fa

FDA drug center head fired after commissioner's exit, replaced by Davis

The U.S. Food and Drug Administration's drug center sees a leadership change as acting head Tracy Beth Hoeg departs, replaced by deputy Michael Davis. This follows Commissioner Marty Makary's exit amid agency-wide…

Leggi questa versione → originale
cnbc.com1 mesi fa

FDA shuffles top drug, biologics leaders in latest shakeup

The U.S. Food and Drug Administration is shuffling its top drug and biologics regulators, days after the departure of former commissioner Marty Makary.

Leggi questa versione → originale
cbsnews.com1 mesi fa

Controversial FDA official leaving drug center post in latest departure at agency

Dr. Tracy Beth Høeg, leader of the Food and Drug Administration division responsible for regulating prescription and over-the-counter drugs, is leaving her post, a senior FDA official confirmed.

Leggi questa versione → originale
huffpost.com1 mesi fa

Trump FDA Chief Is Leaving After Angering Pharma CEOs, Vaping Lobbyists And Anti-Abortion Groups

Marty Makary is resigning after just over a year leading the powerful health regulatory agency.

Leggi questa versione → originale
  • martedì 12 maggio 2026·politico.com

    Makary’s time atop FDA over, Diamantas named acting commissioner

    The gastrointestinal surgeon’s tenure was marked by mass layoffs, persistent churn among senior leaders and policy fights.

  • martedì 12 maggio 2026·usatoday.com

    FDA Commissioner Marty Makary resigns after pressure campaign

    FDA Commissioner Marty Makary resigned, President Donald Trump said, marking the latest high-profile leadership shakeup at HHS.

  • martedì 12 maggio 2026·rollcall.com

    Makary out at FDA after facing pressure to resign

    Food and Drug Administration Commissioner Marty Makary will leave his role, President Donald Trump said Tuesday. Makary’s departure comes after pressure within the administration…

  • mercoledì 13 maggio 2026·biopharmadive.com

    FDA’s leadership void leaves biotech with renewed ‘uncertainty’

    Marty Makary's resignation leaves the agency with temporary directors in three top positions, and a number of newly instituted policies with an unclear future.

  • mercoledì 13 maggio 2026·endpoints.news

    Post-Hoc: What brought down the FDA commissioner

    Marty Makary resigned as FDA commissioner Tuesday. The next commissioner will inherit the same punishing contradictions, and a weaker, politicized agency.

  • giovedì 14 maggio 2026·thedispatch.com

    Marty Makary’s Turbulent Tenure at FDA Comes to an End

    Brought in as an agency critic, the commissioner drew fire from drug developers and abortion foes.

  • giovedì 14 maggio 2026·fiercepharma.com

    Biopharma leaders rally behind Pazdur for FDA commissioner pick. But does he want the role?

    With the FDA now rudderless following the revelation that commissioner Marty Makary, M.D., is stepping down, voices across biopharma have joined in support of the FDA’s former top…

  • venerdì 15 maggio 2026·endpoints.news

    Post-Hoc Live: Marty Makary's FDA downfall and legacy

    Endpoints News and Financial Times journalists discuss the downfall of FDA Commissioner Marty Makary, live in New York at the FT's biotech and pharma summit.

  • venerdì 15 maggio 2026·fiercepharma.com

    After Makary departure, CDER chief Tracy Beth Høeg likely headed out at FDA: report

    With the ink barely dry on outgoing commissioner Marty Makary’s resignation, another top regulator may be heading for the exit at the FDA.  | With the ink barely dry on outgoing…

  • sabato 16 maggio 2026·nbcnews.com

    FDA leadership shake-up continues with departure of top drug regulator

    Dr. Tracy Beth Høeg is leaving her role as head of the FDA’s Center for Drug Evaluation and Research, just days after FDA chief Marty Makary resigned.

  • sabato 16 maggio 2026·cnbc.com

    FDA shuffles top drug, biologics leaders in latest shakeup

    The U.S. Food and Drug Administration is shuffling its top drug and biologics regulators, days after the departure of former commissioner Marty Makary.

  • sabato 16 maggio 2026·cbsnews.com

    Controversial FDA official leaving drug center post in latest departure at agency

    Dr. Tracy Beth Høeg, leader of the Food and Drug Administration division responsible for regulating prescription and over-the-counter drugs, is leaving her post, a senior FDA…

  • sabato 16 maggio 2026·benzinga.com

    FDA Drug Chief Tracey Hoeg Fired Days After After Marty Makary's Exit— Says Order Came From 'Way Above' -

    Tracey Beth Hoeg was fired as FDA drug division chief amid a broader Trump administration shake-up at the health department.

  • sabato 16 maggio 2026·endpoints.news

    Makary resigns; Biogen reports Alzheimer’s data; and more

    Welcome back to Endpoints Weekly. The biggest news this week was Marty Makary’s resignation from his role as FDA Commissioner. The announcement came days after reports emerged…

  • sabato 16 maggio 2026·fortune.com

    RFK ally confirms she was fired by FDA: 'I learned so much and leave with no regrets' | Fortune

    Dr. Tracy Beth Hoeg will be replaced as FDA's acting drug center director by Dr. Mike Davis, who has been serving as deputy director.

  • sabato 16 maggio 2026·economictimes.indiatimes.com

    FDA drug center head fired after commissioner's exit, replaced by Davis

    The U.S. Food and Drug Administration's drug center sees a leadership change as acting head Tracy Beth Hoeg departs, replaced by deputy Michael Davis. This follows Commissioner…

  • lunedì 18 maggio 2026·pharmaceutical-technology.com

    Tracy Beth Høeg ousted from FDA in wider senior leadership shakeup - Pharmaceutical Technology

    The wider US HHS is going through a leadership upheaval, as Republicans aim to keep voters on side amid the looming midterm elections.